Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samar Abd ElHafeez

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Plos One|March 16, 2022
Reliability and validation of an attitude scale regarding responsible conduct in researchSamar Abd ElHafeez, Mohamed Salem, Henry J Silverman
European Journal of Clinical Investigation|September 8, 2015
Aldosterone, mortality, cardiovascular events and reverse epidemiology in end stage renal diseaseSamar Abd ElHafeez, Giovanni Tripepi, Francesca Mallamaci, et al.
Frontiers in Cell and Developmental Biology|July 16, 2021
Editorial: Molecular Mechanisms in Chronic Kidney DiseaseClaudia Torino, Evangelia Dounousi, Samar Abd ElHafeez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 25, 2014
Should we extend the application of more frequent dialysis schedules? A 'yes' and a hopeful 'no'Carmine Zoccali, Evangelia Dounousi, Samar Abd ElHafeez, et al.
The Journal of the Egyptian Public Health Association|February 26, 2019
Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological studySamar Abd ElHafeez, Reem Hegazy, Yasmine Naga, et al.
Oxidative Medicine and Cellular Longevity|December 10, 2021
Methods to Analyze Time-to-Event Data: The Cox Regression AnalysisSamar Abd ElHafeez, Graziella D'Arrigo, Daniela Leonardis, et al.
BMJ Open|January 13, 2018
Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic reviewSamar Abd ElHafeez, Davide Bolignano, Graziella D'Arrigo, et al.
Oxidative Medicine and Cellular Longevity|October 1, 2021
Methods to Analyse Time-to-Event Data: The Kaplan-Meier Survival CurveGraziella D'Arrigo, Daniela Leonardis, Samar Abd ElHafeez, et al.
Prilozi (Makedonska Akademija Na Naukite I Umetnostite. Oddelenie Za Medicinski Nauki)|July 22, 2016
Life-Time Risk, Screening and The Cost of Cardiovascular Comorbidities in CKD PatientsCarmine Zoccali, Samar Abd ElHafeez, Evangelia Dounousi, et al.
The Cochrane Database of Systematic Reviews|May 18, 2026
Interventions for treating COVID-19 in people with chronic kidney diseaseSamar Abd ElHafeez, Patrizia Natale, Kimia Hosseini, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Plos One|March 16, 2022
Reliability and validation of an attitude scale regarding responsible conduct in researchSamar Abd ElHafeez, Mohamed Salem, Henry J Silverman
European Journal of Clinical Investigation|September 8, 2015
Aldosterone, mortality, cardiovascular events and reverse epidemiology in end stage renal diseaseSamar Abd ElHafeez, Giovanni Tripepi, Francesca Mallamaci, et al.
Frontiers in Cell and Developmental Biology|July 16, 2021
Editorial: Molecular Mechanisms in Chronic Kidney DiseaseClaudia Torino, Evangelia Dounousi, Samar Abd ElHafeez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 25, 2014
Should we extend the application of more frequent dialysis schedules? A 'yes' and a hopeful 'no'Carmine Zoccali, Evangelia Dounousi, Samar Abd ElHafeez, et al.
The Journal of the Egyptian Public Health Association|February 26, 2019
Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological studySamar Abd ElHafeez, Reem Hegazy, Yasmine Naga, et al.
Oxidative Medicine and Cellular Longevity|December 10, 2021
Methods to Analyze Time-to-Event Data: The Cox Regression AnalysisSamar Abd ElHafeez, Graziella D'Arrigo, Daniela Leonardis, et al.
BMJ Open|January 13, 2018
Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic reviewSamar Abd ElHafeez, Davide Bolignano, Graziella D'Arrigo, et al.
Oxidative Medicine and Cellular Longevity|October 1, 2021
Methods to Analyse Time-to-Event Data: The Kaplan-Meier Survival CurveGraziella D'Arrigo, Daniela Leonardis, Samar Abd ElHafeez, et al.
Prilozi (Makedonska Akademija Na Naukite I Umetnostite. Oddelenie Za Medicinski Nauki)|July 22, 2016
Life-Time Risk, Screening and The Cost of Cardiovascular Comorbidities in CKD PatientsCarmine Zoccali, Samar Abd ElHafeez, Evangelia Dounousi, et al.
The Cochrane Database of Systematic Reviews|May 18, 2026
Interventions for treating COVID-19 in people with chronic kidney diseaseSamar Abd ElHafeez, Patrizia Natale, Kimia Hosseini, et al.
Pageof 6